Hirose S, Mitsudome A, Yasumoto S, Ogawa A, Muta Y, Tomoda Y: Valproate therapy does not deplete carnitine levels in otherwise healthy children
Carnitine shuttle system Carnitine is primarily described as a key player in the degradation of long chain fatty acids (LCFAs) in the mitochondria via the carnitine shuttle system
Full depth of needle should go in
Rodent-model time courses Rodent-model studies of soft-tissue injury (tendon, ligament, gastrointestinal mucosa) describe protocol-defined endpoints across one to four weeks
UA (16 mg/kg, intravenously) reduced infarct volume, improved neurological function, attenuated the inflammatory response, and improved the benefits of rt-PA (10 mg/kg) in a stroke model [146]
Rucklidge, who was also a member of the meta-analysis team